Details
Servings:
60
1 Softgel Supplies:
Vitamin D3 (cholecalciferol)
250 mcg (10,000 IU) 1,250%
Vitamin K1 (as phytonadione)
187 mcg 156%
Vitamin K2 [as MK-7† (menaquinone-7)]
137 mcg 114%
* Percent Daily Value (%DV) is based on a 2,000 calorie diet.
Other Ingredients :
Sunflower seed oil, gelatin, glycerin, purified water, silicate (color), turmeric extract (color).
Recommendations :
Take one softgel daily with food or as directed by your healthcare practitioner. Do not exceed recommended dosage unless directed by your healthcare practitioner.
If you are pregnant, nursing, taking medication, or taking anticoagulants consult your healthcare practitioner before use. Keep out of reach of children.
Warnings:
Use should be short-term and include regular monitoring of 25-(OH)- and 1,25-(OH)2-vitamin D levels. This product contains vitamin D at a level that exceeds the adult tolerable upper intake level.
Vitamin K2 may counteract the effects of anticoagulation therapy, and therefore is not recommended for patients on blood-thinning medication.
† as MenaQ7 a registered trademark of NattoPharma, Norway; Patented in the United States and Canada. (US Patent Numbers 8,728,553 & 8,354,129; Canada Patent Number 2,347,387).
60
1 Softgel Supplies:
Vitamin D3 (cholecalciferol)
250 mcg (10,000 IU) 1,250%
Vitamin K1 (as phytonadione)
187 mcg 156%
Vitamin K2 [as MK-7† (menaquinone-7)]
137 mcg 114%
* Percent Daily Value (%DV) is based on a 2,000 calorie diet.
Other Ingredients :
Sunflower seed oil, gelatin, glycerin, purified water, silicate (color), turmeric extract (color).
Recommendations :
Take one softgel daily with food or as directed by your healthcare practitioner. Do not exceed recommended dosage unless directed by your healthcare practitioner.
If you are pregnant, nursing, taking medication, or taking anticoagulants consult your healthcare practitioner before use. Keep out of reach of children.
Warnings:
Use should be short-term and include regular monitoring of 25-(OH)- and 1,25-(OH)2-vitamin D levels. This product contains vitamin D at a level that exceeds the adult tolerable upper intake level.
Vitamin K2 may counteract the effects of anticoagulation therapy, and therefore is not recommended for patients on blood-thinning medication.
† as MenaQ7 a registered trademark of NattoPharma, Norway; Patented in the United States and Canada. (US Patent Numbers 8,728,553 & 8,354,129; Canada Patent Number 2,347,387).
Additional Information
| Promotion | N/A |
|---|